Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The mechanism of action of interferon-β in relapsing multiple sclerosis.
Going Against the Tide - How Encephalitogenic T Cells Breach the Blood-Brain Barrier.
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
Association between parasite infection and immune responses in multiple sclerosis.
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function.
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis.
Immunological differences between classical phenothypes of multiple sclerosis.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Bayesian inferences for beta semiparametric-mixed models to analyze longitudinal neuroimaging data.
Diverse functional roles of lipocalin-2 in the central nervous system.
[CHANGES IN THE QUALITATIVE AND QUANTITATIVE COMPOSITION OF GUT MICROBIOTA IN RATS DURING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS].
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis.
Pages
« first
‹ previous
…
202
203
204
205
206
207
208
209
210
…
next ›
last »